Home › Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals
 

Keywords :   


Jubilant Biosys Announces Successful Filing Of Investigational New Drug With US-Based Endo Pharmaceuticals

2013-09-04 06:25:07| drugdiscoveryonline News Articles

Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life Sciences Ltd., announced recently the US FDA acceptance of the IND filing for a novel molecule targeting prostate cancer with Endo Pharmaceuticals of the US

Tags: successful drug filing announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 3A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Post Office sabotaged Horizon probe, says investigator
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
More »